Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct;102(4):602-606.
doi: 10.1016/j.gie.2025.03.1333. Epub 2025 May 29.

Development and validation of the SDLD score: a simplified tool to predict successful endoscopic papillectomy in ampullary lesions

Collaborators, Affiliations

Development and validation of the SDLD score: a simplified tool to predict successful endoscopic papillectomy in ampullary lesions

Kien Vu Trung et al. Gastrointest Endosc. 2025 Oct.

Abstract

Background and aims: Endoscopic papillectomy (EP) is the standard treatment for noninvasive ampullary lesions (ALs), whereas advanced cases require surgery. Managing ALs is challenging and may lead to over- or undertreatment. We developed a score to identify the best candidates for endoscopic or surgical treatment.

Methods: We analyzed 447 patients who underwent EP. The cohort was randomly split into a training set (n = 325) and validation set (n = 122). Logistic regression identified predictors for incomplete resection (R1), which were incorporated into a 4-item score. Performance was assessed using the area under the receiver-operating characteristic curve (AUROC).

Results: Independent predictors for R1 included size ≥30 mm (S), high-grade dysplasia and/or invasive cancer (D), laterally spreading-lesion (L), and bile or pancreatic duct dilation (D), which we named the SDLD score. ALs with 0 to 1 points had the highest complete resection rates (training, 86.0%; validation, 88.5%), whereas ≥2 points significantly increased R1 rates (training, 52.0%; validation, 57.7%; P < .001). The AUROC was 0.792 (training) and 0.708 (validation).

Conclusions: The SDLD score predicts R1 in EP and aids in treatment decisions.

PubMed Disclaimer

Conflict of interest statement

Disclosure The following author received research support for this study from the German Research Foundation and Universität Leipzig within the program of Open Access Publishing: M. Hollenbach. In addition, the following authors disclosed financial relationships: B. Napoleon: Teacher for Boston Scientific, Olympus, and Mauna Kea Technology. M. J. Bruno: Lecturer for and research support from Boston Scientific. S. Gaujoux: Lecturer for Viatris. M. Hollenbach: Lecturer and expert panel member for Fujifilm. All other authors disclosed no financial relationships. Research support for this study was provided by the Karolinska Institute, the European Pancreatic Club/EPC, and the Acibadem Mehmet Ali Aydinlar University for the ninth Pancreas2000 education and research program to M. Löhr and G. Ceyhan.

Publication types

LinkOut - more resources